Literature DB >> 25585346

Different MOG(35-55) concentrations induce distinguishable inflammation through early regulatory response by IL-10 and TGF-β in mice CNS despite unchanged clinical course.

Alyria Teixeira Dias1, Sandra Bertelli Ribeiro De Castro2, Caio César De Souza Alves3, Felipe Pereira Mesquita1, Nathália Stela Visoná De Figueiredo1, Marcilene Gomes Evangelista1, Maria Christina Marques Nogueira Castañon4, Maria Aparecida Juliano5, Ana Paula Ferreira6.   

Abstract

Multiple sclerosis (MS) shows distinct clinical courses. Experimental autoimmune encephalomyelitis (EAE), a model to study multiple sclerosis, can be induced by different protocols, which show distinct cytokine and antibody production. The factors involved in this heterogeneity remain unclear. The relevance of MOG concentration in triggering a regulatory response in the chronic model of EAE is imprecise. The aim of this study was investigate if 100 or 300 μg of MOG(35-55) could induce different EAE profiles. Modifications in the concentration of MOG were able to change the patterns of chemokines, cytokines, percentage of cells, inflammatory infiltrate and the development of a regulatory response. However, these changes were unable to modify the intensity of response, which explains the chronic progression of the disease in both concentrations. The results presented in this study contribute to understanding the intricate mechanisms that trigger EAE and provide insights into the pathogenesis of various forms of MS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal model; Autoimmunity; Cytokines; MOG(35–55); Multiple sclerosis

Mesh:

Substances:

Year:  2015        PMID: 25585346     DOI: 10.1016/j.cellimm.2014.12.009

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  5 in total

1.  Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis.

Authors:  Alyria Teixeira Dias; Sandra Bertelli Ribeiro de Castro; Caio César de Souza Alves; Marcilene Gomes Evangelista; Luan Cristian da Silva; Daniele Ribeiro de Lima Reis; Marco Antonio Machado; Maria Aparecida Juliano; Ana Paula Ferreira
Journal:  Inflamm Res       Date:  2018-04-23       Impact factor: 4.575

2.  Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.

Authors:  Jonathan P C Hasselmann; Hawra Karim; Anna J Khalaj; Subir Ghosh; Seema K Tiwari-Woodruff
Journal:  J Neurosci Methods       Date:  2017-04-08       Impact factor: 2.390

3.  The Dual Immunoregulatory function of Nlrp12 in T Cell-Mediated Immune Response: Lessons from Experimental Autoimmune Encephalomyelitis.

Authors:  Marjan Gharagozloo; Shaimaa Mahmoud; Camille Simard; Tara M Mahvelati; Abdelaziz Amrani; Denis Gris
Journal:  Cells       Date:  2018-08-27       Impact factor: 6.600

4.  MS CD49d+CD154+ Lymphocytes Reprogram Oligodendrocytes into Immune Reactive Cells Affecting CNS Regeneration.

Authors:  Paweł Piatek; Magdalena Namiecinska; Małgorzata Domowicz; Patrycja Przygodzka; Marek Wieczorek; Sylwia Michlewska; Natalia Lewkowicz; Maciej Tarkowski; Przemysław Lewkowicz
Journal:  Cells       Date:  2019-11-25       Impact factor: 6.600

5.  Arctigenin Exerts Neuroprotective Effect by Ameliorating Cortical Activities in Experimental Autoimmune Encephalomyelitis In Vivo.

Authors:  Liangpeng Wei; Zhenyi Xue; Baihui Lan; Shiyang Yuan; Yuanyuan Li; Cunle Guo; Rongxin Zhang; Ran Ding; Hui Shen
Journal:  Front Immunol       Date:  2021-07-19       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.